Mycobacterium recombinant vaccines

Tunisie Medicale

Volumn 79, Issue 2, 2001, Pages 65-81

  Labidi, A H ^a   Estes, R C ^a   David, H L ^a   Bollon, A P ^a  

^a Cytoclonal Pharmaceutics Inc   (United States)

Author keywords

Mycobacteriophge D29; Mycobacterium; Plasmid pAL5000; Recombinant; Vaccine; Vector

Indexed keywords

BACTERIAL VACCINE;

ANTIGEN SPECIFICITY; BACTERIOPHAGE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; MOLECULAR CLONING; PLASMID; REVIEW; TH1 CELL; TH2 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AUTOIMMUNE DISEASES; BACTERIAL VACCINES; HUMANS; HYPERSENSITIVITY; INFECTION; MYCOBACTERIUM; NEOPLASMS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 0034992605     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. The macrophage in neural injury: Numbers, timing and cytokines
2. Therapeutic vaccines
3. Tuberculosis and cancer: Parallels in host responses and therapeutic approaches
4. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens
5. Improving on BCG
6. Immunization against leprosy: Progress and prospects
7. Cloning and DNA sequencing of the Mycobacterium fortuitum var. fortuitum plasmid pAL 5000
8. BCG vaccination of Indian infants in Saskatchewan
9. Tuberculosis studies in Muscogee County, Georgia, VII. A twenty year evaluation of BCG vaccination in a school population
10. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life
11. Trial of BCG vaccines in South India for tuberculosis prevention. The Tuberculosis Prevention Trial, Madras
12. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis
13. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forros of leprosy and Mitsuda-negative contacts
14. Structure of the major triglycosyl phenol phthiocerol of Mycobacterium tuberculosis strain canetti
15. Conjugative transfer of a shuttle plasmid from Escherichia coli to Mycobacterium smegmatis
16. Plan of action for research in the immunology of tuberculosis. Memorandum from a W.H.O. meeting
17. Genetics of mycobacteria
18. Plasmid profiles of Mycobacterium fortuitum complex isolates
19. Cloning and expression of mycobacterial plasmid DNA in Escherichia coli
20. Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL 5000
21. Nucleotide sequence analysis of a 5.0 kilobase plasmid from Mycobacterium fortuitum
22. Gene manipulation in mycobacteria
23. Lysogeny and transformation in mycobacteria: Stable expression of foreign genes
24. Tuberculosis control in the coming decades: An ordinary mortal's guide to the molecular biology of mycobacteria
25. Genetic analysis of superoxidase dismutase, the 23 Kilodalton antigen of Mycobacterium tuberculosis
26. Development of BCG as a recombinant vaccine vehicle
27. Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens
28. Genes for the major protein antigens of Mycobacterium tuberculosis: The etiologic agents of tuberculosis and leprosy share an immunodominant antigen
29. Mycobacteria: Bugs and bugbears
30. Mycobacteriophage vector systems
31. Analysis of variables of plasmid transformation of a bacterial vaccine: Studies on recombinant BCG
32. Functional analysis of pAL 5000, a plasmid from Mycobacterium fortuitum: Construction of a "mini" Mycobacterium - Escherichia coli shuttle vector
33. New use of BCG for recombinant Vaccines
34. Identification of expression signals of mycobacteriophage Bxv1. L1, and TM4 using Escherichia coli-Mycobacterium shuttle plasmids pYUB 75 and pYUB 76 designed to create translational fusion to the Lac Z gene
35. An Escherichia coli - Mycobacterium shuttle cosmid vector pMSC1
36. Genetic transformation of mycobacteria
37. Structural instability of recombinant plasmids in mycobacteria
38. Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL 5000 and pACYC 184: Their use for cloning an antibiotic resistant gene from Mycobacterium fortuitum
39. A new serie of mycobacterial expression vectors for the development of live recombinant vaccines
40. A stable Escherichia coli - Mycobacteria shuttle vector pSO246 in Mycobacterium bovis BCG
41. Construction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria
42. Vectors for Mycobacterium recombinant vaccines
43. Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium
44. Complete nucleotide sequence of pAL 5000, a plasmid from Mycobacterium fortuitum
45. Functional definition of regions necessary for replication and incompatibility in the Mycobacterium fortuitum plasmid pAL 5000
46. Protein - DNA interactions in the Ori region of the Mycobacterium fortuitum plasmid pAL 5000
47. Mutational analysis of the regulatory region of the Mycobacterium plasmid pAL 5000
48. Identification of promoter elements in mycobacteria: Mutational analysis of a high symmetric dual promoter directing the expression of replication genes of the Mycobacterium plasmid pAL 5000
49. Analysis of the replication region of a mycobacterial plasmid pMSC 262
50. Cloning and sequencing of a unique antigen MPT 170 from Mycobacterium tuberculosis H37Rv and expression in BCG using E. coli - Mycobacteria shuttle vector
51. Transposition of an antibiotic resistance element in mycobacteria
52. Construction and use of integrative vectors to express foreign genes in mycobacteria
53. Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis
54. Transposition induced structural instability of Escherichia coli - Mycobacteria shuttle vectors
55. Humoral and cell - Mediated immune response to live recombinant BCG - HIV vaccines
56. Gene replacement by homologous recombination in Mycobacterium bovis BCG
57. The potential for a more effective TB vaccine